Identifying key components from Melastoma dodecandrum in TNF-α-induced osteoblast injury model through a combination of cell membrane chromatography and mass spectrometry

• Published in: Journal of ethnopharmacology Vol. 337; no. Pt 2; p. 118836
• Main Authors: Mao, Jiale, Lei, Houxing, Xu, Pingcui, Liu, Shuang, Zhou, Jiwang, Mei, Mingrong, Wang, Nani, Zhang, Xiaoqin
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 30.01.2025
• Subjects: Cell membrane chromatography; Isovitexin; Key component; Melastoma dodecandrum; TNF-α; Key component; Cell membrane chromatography; Isovitexin; TNF-α; Melastoma dodecandrum
• ISSN: 0378-8741; 1872-7573; 1872-7573
• DOI: 10.1016/j.jep.2024.118836

Melastoma dodecandrum (MD), a traditional ethnomedicine, has been widely used for the treatment of fractures, osteoarthritis, and osteoporosis due to its remarkable anti-inflammatory activity. However, the specific active components responsible for its therapeutic effects on orthopedic conditions remain unidentified. This study aimed to screen and identify key active components in MD using a combination of cell membrane chromatography and mass spectrometry, followed by cellular validation. A TNF-α-induced osteoblast injury model and an osteoblast membrane chromatography screening system were established to select and identify chemical components of MD that directly act on osteoblasts. The protective effects of MD on osteoblasts were assessed by evaluating cell viability, alkaline phosphatase (ALP) activity, cell mineralization and the expression of osteogenesis-related proteins OCN, RUNX2, and the TNF-α receptor protein TNFR1. Validation of the activity of individual components was also conducted. MD significantly improved the viability of osteoblasts under TNF-α-induced injury, enhanced ALP activity, stimulated the expression of OCN and RUNX2 proteins, and decreased the expression of TNFR1. Cell membrane chromatography screening identified 32 chemical components, including 21 flavonoids, 6 organic acids, 2 phenylpropanoids, 2 terpenes, and 1 nucleotide. Molecular docking revealed that isovitexin could bind to the specific receptor TNFR1 on the cell membrane. Furthermore, cellular validation demonstrated that isovitexin significantly protected osteoblasts. MD and its pharmacologically active component, isovitexin, exhibit protective effects against TNF-α-induced inflammatory injury in osteoblasts, laying a solid foundation for future drug development. [Display omitted] •Established TNF-α Induced osteoblast injury model and osteoblast membrane chromatographic screening system.•A total of 32 chemical constituents of Melastoma dodecandrum which act directly on osteoblasts were found.•Identified isovitexin as an active component of Melastoma dodecandrum with the ability to ameliorate TNF-α mediated osteoblast injury.